LGALS1 and cancer: While our study aims to mitigate the influence of confounding variables on galectin-1, -3, and -9 levels by examining patients’ demographic factors and cancer stage, we have not accounted for other potential factors that may affect galectin levels, such as comorbidities, lifestyle factors, or genetic predispositions.